Diabetes Mellitus is worldwide clinical complication it is slow killer disease when left untreated can cause death. and can be manage in early stage by diet management and proper exercise along with medication.

Substantial improvements in Tuberculosis indicators had been achieved in the preceding years. However, as Indian health system continues to combat Covid-19 pandemic with full intensity and vigor, the other silent pandemic of Tuberculosis is getting overlooked. More than 10 lakhs TB notifications have been omitted in year 2020. This gap poses serious challenges for the forthcoming years. It is predicted that these missed cases are likely to add lakhs of additional TB cases and increased TB mortality in imminent future. This article examines the current scenario, Covid-19 pandemic effect on TB notifications and the possible measures to avoid the erosion of achievements in TB control. The data was collected through scientific journals, media articles, WHO (World Health Organization) global TB reports and annual TB reports by NTEP (National TB Elimination Program), Ministry of Health and Family Welfare, Government of India. The hour calls for urgent catch up on 2020 oversight and steadfastly pursue TB elimination by 2025 irrespective of Covid-19 pandemic. 

This study aims to look at the causes of COVID-19 vaccine hesitancy in Bangladesh by examining the cultural and religious values, lack of trust, misinformation, and fear of side effects as predictors of vaccine hesitancy. Self-developed measurement items, developed based on the expert's opinion, were used to accomplish the objective. Data was gathered from 268 respondents who represented their community through both an online and a physical survey. SPSS version 25 was used to optimize descriptive statistics. Besides, SmartPLS 3.0 was used to examine the hypotheses using the PLS-SEM approach. The study confirms that lack of trust, misinformation and fear of side effects all play a role in vaccine hesitancy. Besides, the results have many significant implications for public health policymakers, vaccine manufacturers and distributors, and the media. Besides that, the study proposes some new research avenues for overcoming this study's limitations and gaining more detailed information on the topic.